Key Metrics
CiteScore 

1
Recommended pre-submission checks
Powered by 

Chinese Journal of Cardiology Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Chinese Medical Journals Publishing House Co.Ltd |
Planning to publish in Chinese Journal of Cardiology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Chinese Journal of Cardiology
Impact of the mismatch between respiratory event frequency and hypoxic burden on cardiovascular outcomes in patients with obstructive sleep apnea
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Efficacy and safety of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with acute coronary syndrome without standard modifiable cardiovascular risk factors
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Expert advisory on screening and diagnosis of inflammatory risk in coronary artery disease
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
PRDX1 attenuates hypertensive endothelial dysfunction by inhibiting mTOR/p70S6K signaling
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Progress of factor Ⅺ inhibitors in cardiovascular diseases
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Optimized antithrombotic therapy for coronary artery disease: current status and future perspectives
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Impact of the mismatch between respiratory event frequency and hypoxic burden on cardiovascular outcomes in patients with obstructive sleep apnea
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Efficacy and safety of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with acute coronary syndrome without standard modifiable cardiovascular risk factors
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Expert advisory on screening and diagnosis of inflammatory risk in coronary artery disease
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
PRDX1 attenuates hypertensive endothelial dysfunction by inhibiting mTOR/p70S6K signaling
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Progress of factor Ⅺ inhibitors in cardiovascular diseases
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi
Optimized antithrombotic therapy for coronary artery disease: current status and future perspectives
- 24 Jun 2026
- Zhonghua xin xue guan bing za zhi